The National Institute on Drug Abuse is offering a grant to support projects utilizing genome or epigenome editing to validate genes or variants related to substance use disorders. Researchers are encouraged to generate genetic resources for wider scientific use, facilitating the study of neurobiological mechanisms and informing future prevention and treatment strategies. Closing date for application is December 17, 2021.
Opportunity ID: 315739
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-278 |
| Funding Opportunity Title: | Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 08, 2019 |
| Last Updated Date: | May 08, 2019 |
| Original Closing Date for Applications: | Dec 17, 2021 |
| Current Closing Date for Applications: | Dec 17, 2021 |
| Archive Date: | Jan 22, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Private institutions of higher education State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public housing authorities/Indian housing authorities County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-278.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00250805 | May 24, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260078 | May 24, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270261 | Nov 16, 2021 | Dec 17, 2021 | View |
Package 1
Mandatory forms
315739 RR_SF424_2_0-2.0.pdf
315739 PHS398_CoverPageSupplement_4_0-4.0.pdf
315739 RR_OtherProjectInfo_1_4-1.4.pdf
315739 PerformanceSite_2_0-2.0.pdf
315739 RR_KeyPersonExpanded_2_0-2.0.pdf
315739 RR_Budget_1_4-1.4.pdf
315739 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
315739 RR_SubawardBudget30_1_4-1.4.pdf
315739 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
315739 RR_SF424_2_0-2.0.pdf
315739 PHS398_CoverPageSupplement_5_0-5.0.pdf
315739 RR_OtherProjectInfo_1_4-1.4.pdf
315739 PerformanceSite_2_0-2.0.pdf
315739 RR_KeyPersonExpanded_2_0-2.0.pdf
315739 RR_Budget_1_4-1.4.pdf
315739 PHS398_ResearchPlan_4_0-4.0.pdf
315739 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
315739 RR_SubawardBudget30_1_4-1.4.pdf
315739 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
315739 RR_SF424_5_0-5.0.pdf
315739 PHS398_CoverPageSupplement_5_0-5.0.pdf
315739 RR_OtherProjectInfo_1_4-1.4.pdf
315739 PerformanceSite_4_0-4.0.pdf
315739 RR_KeyPersonExpanded_4_0-4.0.pdf
315739 RR_Budget_3_0-3.0.pdf
315739 PHS398_ResearchPlan_4_0-4.0.pdf
315739 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
315739 RR_SubawardBudget30_3_0-3.0.pdf
315739 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
